TREZZI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 3.270
AS - Asia 2.279
EU - Europa 1.635
SA - Sud America 464
AF - Africa 71
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.724
Nazione #
US - Stati Uniti d'America 3.163
SG - Singapore 911
CN - Cina 462
IT - Italia 376
BR - Brasile 347
HK - Hong Kong 297
DE - Germania 277
RU - Federazione Russa 272
VN - Vietnam 254
IE - Irlanda 197
SE - Svezia 128
GB - Regno Unito 71
FR - Francia 63
IN - India 57
CA - Canada 56
FI - Finlandia 48
AT - Austria 42
AR - Argentina 38
BD - Bangladesh 38
TR - Turchia 35
KR - Corea 34
ZA - Sudafrica 30
ES - Italia 29
UA - Ucraina 29
MX - Messico 28
NL - Olanda 28
PK - Pakistan 28
JP - Giappone 26
ID - Indonesia 24
PL - Polonia 22
EC - Ecuador 21
IQ - Iraq 21
PH - Filippine 16
CL - Cile 14
CO - Colombia 14
EG - Egitto 14
VE - Venezuela 14
DK - Danimarca 11
SA - Arabia Saudita 11
MA - Marocco 8
IL - Israele 7
MY - Malesia 7
UZ - Uzbekistan 7
IR - Iran 6
JM - Giamaica 6
JO - Giordania 6
LT - Lituania 6
PY - Paraguay 6
AL - Albania 5
AZ - Azerbaigian 5
UY - Uruguay 5
AU - Australia 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
KZ - Kazakistan 4
PA - Panama 4
RO - Romania 4
TH - Thailandia 4
BE - Belgio 3
DZ - Algeria 3
HN - Honduras 3
LB - Libano 3
PE - Perù 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KE - Kenya 2
LY - Libia 2
PT - Portogallo 2
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MG - Madagascar 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
Totale 7.717
Città #
Singapore 580
Ann Arbor 509
Ashburn 323
Hong Kong 288
San Jose 262
Chandler 196
Frankfurt am Main 195
Dublin 192
Woodbridge 167
Fairfield 129
New York 97
Beijing 93
Wilmington 90
Dallas 88
Ho Chi Minh City 81
Los Angeles 80
Milan 74
The Dalles 66
Hanoi 64
Hefei 58
Chicago 56
Houston 53
Seattle 51
Shanghai 49
Princeton 48
Santa Clara 48
Cambridge 41
Jacksonville 40
São Paulo 38
Lissone 34
Moscow 34
Munich 33
Seoul 32
Dearborn 30
Vienna 30
Lauterbourg 29
Buffalo 26
Altamura 23
Lawrence 22
Tokyo 20
Jakarta 17
London 17
Nanjing 17
Turku 17
Warsaw 17
Brooklyn 16
Helsinki 15
Montreal 15
Johannesburg 14
Orem 14
Nuremberg 13
Rome 13
Toronto 13
Ottawa 12
Chennai 11
Da Nang 11
Lachine 11
Columbus 10
Denver 10
Rio de Janeiro 10
San Diego 10
Andover 9
Boardman 9
Caronno Pertusella 9
Council Bluffs 9
Istanbul 9
Lahore 9
Mexico City 9
Alexandria 8
Brasília 8
Guangzhou 8
Hangzhou 8
Phoenix 8
Xi'an 8
Baghdad 7
Belo Horizonte 7
Bologna 7
Buenos Aires 7
Campinas 7
Changsha 7
Charlotte 7
Curitiba 7
Pavia 7
Quito 7
San Francisco 7
Shenyang 7
Stockholm 7
Tashkent 7
Boston 6
Cape Town 6
Caracas 6
Jinan 6
Manchester 6
Melzo 6
Roubaix 6
Tel Aviv 6
Thái Nguyên 6
Atlanta 5
Biên Hòa 5
Detroit 5
Totale 4.930
Nome #
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 346
Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient) 338
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis 316
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 301
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 294
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 283
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 281
Neutrophil Extracellular Traps in the Autoimmunity Context 268
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 267
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 263
Novel Therapies in Takayasu Arteritis 261
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) 250
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 238
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens 228
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 224
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 222
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 220
Evidence for charge-based mimicry in anti dsDNA antibody generation 214
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 211
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy 210
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 204
Immunology of membranous nephropathy: From animal models to humans 202
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 200
Clinical evaluation of a rapid immunofluorescence test (IIFT) for diagnosis of ANCA-associated vasculitis 191
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 190
Second wave antibodies in autoimmune renal diseases: The case of lupus nephritis 190
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 185
Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritis 181
Anti-M-Type Phospholipase A2 Receptor (PLA2R) Antibodies: Diagnostic Performance and Clinical Significance in Idiopathic Membranous Nephropathy (IMN) 171
ANCA-associated vasculitides (AAV) from the gender point of view 171
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 159
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 156
Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in Lupus Nephritis 156
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 148
Clinical presentation, outcomes and risk of relapses of lupus podocytopathy in a multicentre Italian cohort 140
Totale 7.879
Categoria #
all - tutte 25.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.137


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021103 0 0 0 0 0 0 0 0 0 0 44 59
2021/2022387 47 67 48 33 11 22 10 22 15 20 36 56
2022/2023738 69 236 101 60 45 105 10 40 43 7 14 8
2023/2024567 17 11 33 22 55 183 103 16 36 17 9 65
2024/20251.617 59 120 127 73 113 59 141 50 184 300 169 222
2025/20263.256 442 208 305 406 455 208 526 158 238 279 31 0
Totale 7.879